1. Home
  2. NVAX vs KW Comparison

NVAX vs KW Comparison

Compare NVAX & KW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • KW
  • Stock Information
  • Founded
  • NVAX 1987
  • KW 1977
  • Country
  • NVAX United States
  • KW United States
  • Employees
  • NVAX N/A
  • KW N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • KW Real Estate
  • Sector
  • NVAX Health Care
  • KW Finance
  • Exchange
  • NVAX Nasdaq
  • KW Nasdaq
  • Market Cap
  • NVAX 1.4B
  • KW 1.4B
  • IPO Year
  • NVAX 1995
  • KW 1992
  • Fundamental
  • Price
  • NVAX $8.38
  • KW $8.99
  • Analyst Decision
  • NVAX Buy
  • KW Hold
  • Analyst Count
  • NVAX 6
  • KW 1
  • Target Price
  • NVAX $17.83
  • KW $13.00
  • AVG Volume (30 Days)
  • NVAX 4.8M
  • KW 556.8K
  • Earning Date
  • NVAX 02-26-2025
  • KW 02-26-2025
  • Dividend Yield
  • NVAX N/A
  • KW 5.39%
  • EPS Growth
  • NVAX N/A
  • KW N/A
  • EPS
  • NVAX N/A
  • KW N/A
  • Revenue
  • NVAX $885,193,000.00
  • KW $483,200,000.00
  • Revenue This Year
  • NVAX N/A
  • KW N/A
  • Revenue Next Year
  • NVAX N/A
  • KW N/A
  • P/E Ratio
  • NVAX N/A
  • KW N/A
  • Revenue Growth
  • NVAX N/A
  • KW N/A
  • 52 Week Low
  • NVAX $3.60
  • KW $7.85
  • 52 Week High
  • NVAX $23.86
  • KW $11.88
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 45.04
  • KW 37.77
  • Support Level
  • NVAX $8.30
  • KW $8.75
  • Resistance Level
  • NVAX $9.77
  • KW $9.35
  • Average True Range (ATR)
  • NVAX 0.56
  • KW 0.23
  • MACD
  • NVAX -0.06
  • KW 0.04
  • Stochastic Oscillator
  • NVAX 12.67
  • KW 29.27

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

About KW Kennedy-Wilson Holdings Inc.

Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.

Share on Social Networks: